{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:27:28Z","timestamp":1791293248176,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":920,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1038\/mt.2013.289","type":"journal-article","created":{"date-parts":[[2014,1,6]],"date-time":"2014-01-06T07:22:17Z","timestamp":1388992937000},"page":"797-810","source":"Crossref","is-referenced-by-count":70,"title":["Intrajugular Vein Delivery of AAV9-RNAi Prevents Neuropathological Changes and Weight Loss in Huntington's Disease Mice"],"prefix":"10.1016","volume":"22","author":[{"given":"Brett D","family":"Dufour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall L","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi L","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2013.289_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1038\/mt.2013.289_bib2","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00001756-199806010-00028","article-title":"Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset","volume":"9","author":"Gourfinkel-An","year":"1998","journal-title":"Neuroreport"},{"key":"10.1038\/mt.2013.289_bib3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/mt.2013.289_bib4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00310376","article-title":"Cortical and striatal neurone number in Huntington's disease","volume":"88","author":"Heinsen","year":"1994","journal-title":"Acta Neuropathol"},{"issue":"Suppl","key":"10.1038\/mt.2013.289_bib5","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/0303-8467(92)90064-A","article-title":"The spectrum of motor disorders in Huntington's disease","volume":"94","author":"Yanagisawa","year":"1992","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1038\/mt.2013.289_bib6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/jnnp.56.5.487","article-title":"Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection","volume":"56","author":"Spargo","year":"1993","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1038\/mt.2013.289_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-010-0742-6","article-title":"Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses","volume":"120","author":"Gabery","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1038\/mt.2013.289_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-510X(81)90049-6","article-title":"Cerebellar atrophy in Huntington's disease","volume":"50","author":"Rodda","year":"1981","journal-title":"J Neurol Sci"},{"key":"10.1038\/mt.2013.289_bib9","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","article-title":"Weight loss in Huntington disease increases with higher CAG repeat number","volume":"71","author":"Aziz","year":"2008","journal-title":"Neurology"},{"key":"10.1038\/mt.2013.289_bib10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nut.2003.10.007","article-title":"Assessment of the nutrition status of patients with Huntington's disease","volume":"20","author":"Trejo","year":"2004","journal-title":"Nutrition"},{"key":"10.1038\/mt.2013.289_bib11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1038\/mt.2013.289_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington's disease","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1038\/mt.2013.289_bib13","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2013.289_bib14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","article-title":"Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington's disease transgenic mice","volume":"12","author":"Rodriguez-Lebron","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.289_bib15","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/mt.2008.50","article-title":"AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease","volume":"16","author":"Franich","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.289_bib16","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.289_bib17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1038\/mt.2013.289_bib18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"10.1038\/mt.2013.289_bib19","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/mt.2011.219","article-title":"Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease","volume":"19","author":"McBride","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.289_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.nbd.2011.12.030","article-title":"Gene therapy for Huntington's disease","volume":"48","author":"Ramaswamy","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2013.289_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2013.289_bib22","doi-asserted-by":"crossref","first-page":"e4962","DOI":"10.1371\/journal.pone.0004962","article-title":"Neuroendocrine disturbances in Huntington's disease","volume":"4","author":"Saleh","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1038\/mt.2013.289_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng1193-259","article-title":"Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues","volume":"5","author":"Strong","year":"1993","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2013.289_bib24","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2013.289_bib25","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/mt.2011.185","article-title":"Rational design of therapeutic siRNAs: minimizing off-targeting potential to improve the safety of RNAi therapy for Huntington's disease","volume":"19","author":"Boudreau","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.289_bib26","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2013.289_bib27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ymthe.2003.08.021","article-title":"Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain","volume":"8","author":"Fu","year":"2003","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.289_bib28","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/mt.2011.34","article-title":"Correction of neurological disease of mucopolysaccharidosis IIIB in adult mice by rAAV9 trans-blood-brain barrier gene delivery","volume":"19","author":"Fu","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.289_bib29","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/gt.2009.85","article-title":"Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MPS IIIB mice","volume":"16","author":"McCarty","year":"2009","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2013.289_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jns.2011.12.014","article-title":"NGF and nitrosative stress in patients with Huntington's disease","volume":"315","author":"Tasset","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1038\/mt.2013.289_bib31","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2011.02.013","article-title":"Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits","volume":"13","author":"Hult","year":"2011","journal-title":"Cell Metab"},{"key":"10.1038\/mt.2013.289_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2013.289_bib33","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.0508875103","article-title":"Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease","volume":"103","author":"McBride","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2013.289_bib34","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","article-title":"Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease","volume":"23","author":"Yu","year":"2003","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2013.289_bib35","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.neuroimage.2011.02.022","article-title":"Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model","volume":"56","author":"Cheng","year":"2011","journal-title":"Neuroimage"},{"key":"10.1038\/mt.2013.289_bib36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2013.289_bib37","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1089\/hum.2009.182","article-title":"Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors","volume":"21","author":"Boutin","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2013.289_bib38","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/mt.2011.72","article-title":"Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates","volume":"19","author":"Gray","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.289_bib39","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1089\/hum.2011.200","article-title":"Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates","volume":"23","author":"Samaranch","year":"2012","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2013.289_bib40","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood-2007-02-073304","article-title":"Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer","volume":"110","author":"Cao","year":"2007","journal-title":"Blood"},{"key":"10.1038\/mt.2013.289_bib41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/mt.2012.167","article-title":"Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses","volume":"21","author":"Ciesielska","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.289_bib42","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/mt.2013.156","article-title":"Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of alpha-dystroglycan and improves muscle functions","volume":"21","author":"Xu","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.289_bib43","doi-asserted-by":"crossref","first-page":"e000078","DOI":"10.1161\/JAHA.113.000078","article-title":"Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling","volume":"2","author":"Karakikes","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1038\/mt.2013.289_bib44","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/gt.2013.16","article-title":"Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery","volume":"20","author":"Katwal","year":"2013","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2013.289_bib45","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/mt.2010.240","article-title":"Efficacy and safety of long-term prophylaxis in severe hemophilia A dogs following liver gene therapy using AAV vectors","volume":"19","author":"Sabatino","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.289_bib46","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/mt.2012.261","article-title":"Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice","volume":"21","author":"Benkhelifa-Ziyyat","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.289_bib47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/mt.2012.200","article-title":"Improved survival and reduced phenotypic severity following AAV9\/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice","volume":"21","author":"Gadalla","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.289_bib48","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.1523\/JNEUROSCI.1854-13.2013","article-title":"Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome","volume":"33","author":"Garg","year":"2013","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2013.289_bib49","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/mt.2013.211","article-title":"Therapeutic AAV9-mediated Suppression of Mutant SOD1 Slows Disease Progression and Extends Survival in Models of Inherited ALS","volume":"21","author":"Foust","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.289_bib50","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/mt.2009.128","article-title":"A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells","volume":"17","author":"Smith","year":"2009","journal-title":"Mol Ther"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616312060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616312060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T18:09:58Z","timestamp":1565028598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616312060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1525001616312060"],"URL":"https:\/\/doi.org\/10.1038\/mt.2013.289","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}